Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
856.00    11.00 (1.30%)
Bid:
860.00
Ask:
861.00
Spread: 1.00 (0.116%)
Market Cap: £1.19b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Chair Succession

10 Aug 2023 07:00

RNS Number : 8567I
Savills PLC
10 August 2023
 

 

 

10 August 2023

 

 

SAVILLS PLC

("Savills" or the "Group")

 

Chair Succession

 

Savills plc, the international real estate advisor, announces that Stacey Cartwright will succeed Nicholas Ferguson as Chair of Savills when he retires from the Board effective 31 December 2023.

 

Stacey has been an independent non-executive director of Savills since October 2018, and Senior Independent Director since January 2021. She brings extensive leadership experience, having been Chief Executive Officer and subsequently Deputy Chair of Harvey Nicholls plc (2014-18), Executive Vice President and Chief Financial Officer of Burberry plc (2004-13) and Chief Financial Officer of Egg plc (1999-2003). Stacey is also currently a non-executive director of AerCap Holdings N.V., Genpact Ltd, Gymshark and Majid al Futtaim (MAF) Entertainment.

Mark Ridley, Chief Executive Officer, said:

"On behalf of everyone at Savills I thank Nicholas for his leadership of the Board since 2016 and for the huge contribution he has made to the development of the Company over the past seven years. We wish him all the best for the future.

"I am delighted that Stacey will be Savills next Chair. I greatly look forward to her continued contribution and guidance as we seek to deliver the Group's long-term strategic objectives."

Commenting, Nicholas Ferguson said, "I am delighted that Savills has appointed Stacey Cartwright to succeed me as Chair. Over the last seven years, the Group has made huge progress and I am proud of the strong platform for future growth that we have built".

 

For further information, contact:

 

Savills

020 7409 8030

Nicholas Ferguson, Chairman

Mark Ridley, Group Chief Executive

 Teneo

020 7353 4200

Jo Blackshaw

Will Palfreyman

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGRNLRGFZM
Date   Source Headline
19th Jun 20262:28 pmRNSDirector/PDMR Shareholding
18th Jun 202611:37 amRNSDirector/PDMR Shareholding
11th Jun 20263:20 pmRNSDirector/PDMR Shareholding
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.